CFML
FBT icon

COMPASS FINANCIAL MANAGEMENT LLC’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146K Buy
+588
New +$127K 0.02% 482

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's FBT Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 588 shares worth $146K. The stake represents 0.02% of the portfolio and ranks #482 among its holdings.

279 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • COMPASS FINANCIAL MANAGEMENT LLC held 588 shares of First Trust NYSE Arca Biotechnology Index Fund worth $146K as of Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #482 holding.
  • 279 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.